Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Art Pappas will be speaking on two panels, Starting Up Biotechs in the New Normal World and Success in the States: A Guide for Foreign Companies to the Largest Venture Capital Pool in the World, at the Bio 2011 conference in Washington, D.C.
News | 06. 29. 2011
